Nile Therapeutics Phase 2 Study of CD-NP in Patients With Acute Decompensated ... - MarketWatch (press release) PDF Print
MarketWatch (press release)Secondary and exploratory analyses demonstrated favorable effects of CD-NP on renal function, particularly at the 1.25 and 2.5 ng/kg/min doses.

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.